Prosecution Insights
Prosecution Insights
73 pending office actions • 36 clients • 66 examiners • 45 art units • 0 of 73 (0%) have an AI response strategy ready • 118 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 73 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 73 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (1%) |
| §103 only | 42 (58%) |
| §102 only | 9 (12%) |
| §112 only | 3 (4%) |
| Double-patenting + other | 1 (1%) |
| No statute on record | 17 (23%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TRUONG, BAO Q | 2 | 83.6% | +13.3% |
| FAIRCHILD, MALLIKA DIPAYAN | 2 | 79.4% | +18.5% |
| BLAISE, BRADFORD CHRISTOPHER | 2 | 59.7% | +34.1% |
| GODDARD, LAURA B | 2 | 50.7% | +14.6% |
| SALMON, KATHERINE D | 2 | 42.6% | +38.0% |
| DAUNER, JOSEPH G | 2 | 56.8% | +34.8% |
| ZHANG, KAIJIANG | 2 | 76.5% | +35.3% |
| SONG, ZHENG B | 1 | 70.3% | +14.6% |
| LUAN, SCOTT | 1 | 64.6% | +12.3% |
| SCHMID, BROOK VICTORIA | 1 | 30.0% | +63.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18924544 | ARTIFICIAL TREES WITH WIRELESS POWER TRANSMISSION | TRUONG, BAO Q | 44d overdue |
| 19218869 | WIRELESSLY POWERED DECORATIVE SYSTEMS AND DEVICES | TRUONG, BAO Q | 30d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16630547 | DNA TARGETS AS TISSUE-SPECIFIC METHYLATION MARKERS | WOOLWINE, SAMUEL C | 29d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17393609 | DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE | DAUNER, JOSEPH G | 132d overdue |
| 19094775 | PESTICIDAL DEVICE AND DELIVERY METHOD THEREOF | SCHMID, BROOK VICTORIA | 98d overdue |
| 17900935 | DUAL-PROBE DIGITAL DROPLET PCR STRATEGY FOR SPECIFIC DETECTION OF TISSUE-SPECIFIC CIRCULATING DNA MOLECULES | DAUNER, JOSEPH G | 88d overdue |
| 17384251 | DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE | SALMON, KATHERINE D | 84d overdue |
| 17746361 | APPLYING PULSED ELECTRIC FIELDS IN THE TREATMENT OF NEURAL DISORDERS | BLAISE, BRADFORD CHRISTOPHER | 71d overdue |
| 18416505 | DEVICES, SYSTEMS AND METHODS FOR THE TREATMENT OF ABNORMAL TISSUE | BLAISE, BRADFORD CHRISTOPHER | 59d overdue |
| 18924544 | ARTIFICIAL TREES WITH WIRELESS POWER TRANSMISSION | TRUONG, BAO Q | 44d overdue |
| 19218869 | WIRELESSLY POWERED DECORATIVE SYSTEMS AND DEVICES | TRUONG, BAO Q | 30d overdue |
| Art Unit | Apps |
|---|---|
| 1682 | 7 |
| 3792 | 4 |
| 3794 | 4 |
| 1681 | 4 |
| 1684 | 4 |
| 2875 | 3 |
| 1636 | 3 |
| 2844 | 2 |
| 1692 | 2 |
| 1678 | 2 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19263093 | ELECTRIC LIGHTING SYSTEMS WITH REMOVABLY COUPLABLE POWER DEVICES | Belgravia Wood Limited | SONG, ZHENG B | 2875 | §103 | Non-Final OA | 1d overdue | Pending | Jul 08, 2025 |
| 19261971 | CO-MANIPULATION SURGICAL SYSTEM HAVING INSTRUMENT-BASED MODE SWITCHING | Moon Surgical SAS | LUAN, SCOTT | 3792 | §103 | Final Rejection | 70d | Pending | Jul 07, 2025 |
| 19218869 | WIRELESSLY POWERED DECORATIVE SYSTEMS AND DEVICES | Belgravia Wood Limited | TRUONG, BAO Q | 2875 | §103 | Non-Final OA | 30d overdue | Pending | May 27, 2025 |
| 19094775 | PESTICIDAL DEVICE AND DELIVERY METHOD THEREOF | Ross Lifescience Usa Inc. | SCHMID, BROOK VICTORIA | 3642 | §102 | Non-Final OA | 98d overdue | Pending | Mar 28, 2025 |
| 19009543 | INFLATABLE PILLOW | Ballast Outdoor Gear, Ll. | KURILLA, ERIC J | 3619 | Other | Non-Final OA | 15d overdue | Pending | Jan 03, 2025 |
| 18924544 | ARTIFICIAL TREES WITH WIRELESS POWER TRANSMISSION | Belgravia Wood Limited | TRUONG, BAO Q | 2875 | §102 | Final Rejection | 44d overdue | Pending | Oct 23, 2024 |
| 18893766 | SYSTEM AND METHOD FOR CONTROLLING DECORATIVE LIGHTING | Belgravia Wood Limited | TRAN, ANH Q | 2844 | §103 | Non-Final OA | 36d overdue | Pending | Sep 23, 2024 |
| 18828987 | VARIABLE MULTI-COLOR LED LIGHT STRING AND CONTROLLER FOR AN ARTIFICIAL TREE | Belgravia Wood Limited | CRAWFORD, JASON | 2844 | Other | Non-Final OA | 23d overdue | Pending | Sep 09, 2024 |
| 18784828 | STATISTICAL METHODS AND SYSTEMS FOR DETECTING PERFORATIONS DURING SURGICAL DRILLING BASED ON SENSED ELECTRICAL CHARACTERISTICS | INSERM | KU, SI MING | 3775 | §103 | Final Rejection | 117d overdue | Pending | Jul 25, 2024 |
| 18676020 | IMPLANTABLE PUMP SYSTEM HAVING AN UNDULATING MEMBRANE | Corwave SA | TEJANI, ANKIT D | 3796 | Other | Non-Final OA | 9d | Pending | May 28, 2024 |
| 18645220 | METHODS, APPARATUSES, AND SYSTEMS FOR THE TREATMENT OF DISEASE STATES AND DISORDERS | Galvanize Therapeutics, Inc. | VOORHEES, CATHERINE M | 3792 | §103 | Non-Final OA | 5d overdue | Pending | Apr 24, 2024 |
| 18589079 | ELECTRO-STIMULATION SYSTEMS AND METHODS FOR REHABILITATION AND TREATMENT OF PELVIC DISORDERS | Comphya SA | FAIRCHILD, MALLIKA DIPAYAN | 3792 | Other | Non-Final OA | 8d | Pending | Feb 27, 2024 |
| 18442958 | SYSTEMS AND METHODS FOR MANAGEMENT OF VIRTUAL AGENTS | Interwoven Worlds Inc. | BLAISE, MALINA D | 3715 | §103 | Non-Final OA | 97d overdue | Pending | Feb 15, 2024 |
| 18416809 | CONTROLLED LESION AND IMMUNE RESPONSE TO PULSED ELECTRIC FIELD THERAPY | Galvanize Therapeutics , Inc. | FOWLER, DANIEL WAYNE | 3794 | §103 | Final Rejection | 81d overdue | Pending | Jan 18, 2024 |
| 18416505 | DEVICES, SYSTEMS AND METHODS FOR THE TREATMENT OF ABNORMAL TISSUE | Galvanize Therapeutics, Inc. | BLAISE, BRADFORD CHRISTOPHER | 3794 | §103 | Non-Final OA | 59d overdue | Pending | Jan 18, 2024 |
| 18408651 | TISSUE ANCHORING DEVICE | Endoron Medical Ltd. | RODJOM, KATHERINE MARIE | 3771 | §102 | Final Rejection | 15d | Pending | Jan 10, 2024 |
| 18406611 | DATA SECURITY FOR PORTABLE STORAGE MEDIUMS | Secturion Systems, Inc. | BINCZAK, BRANDON MICHAEL | 2437 | §103 | Final Rejection | 22d | Pending | Jan 08, 2024 |
| 18538995 | TISSUE-SPECIFIC METHYLATION MARKER | Grail, Inc. | SITTON, JEHANNE SOUAYA | 1682 | Other | Final Rejection | 49d overdue | Pending | Dec 13, 2023 |
| 18500032 | Method for Treating Blood Cancers | Lantern Pharma Inc. | BARSKY, JARED | 1628 | §103 | Non-Final OA | 49d overdue | Pending | Nov 01, 2023 |
| 18554448 | PHOSPHOKETOLASE VARIANTS AND METHODS OF USE | Genomatica, Inc. | BERKE-SCHLESSEL, DAVID W | 1651 | §103 | Non-Final OA | 34d | Pending | Oct 06, 2023 |
| 18472535 | MULTI-ELECTRODE SYSTEM AND METHOD FOR DEDUCING TREATMENT EFFECT OUTCOMES | Galvanize Therapeutics, Inc. | PEFFLEY, MICHAEL F | 3794 | §103 | Final Rejection | 49d | Pending | Sep 22, 2023 |
| 18469170 | PROCESS AND SYSTEMS FOR OBTAINING 1,3-BUTANEDIOL FROM FERMENTATION BROTHS | Genomatica, Inc. | MURESAN, ANA Z | 1692 | §103 | Final Rejection | 13d | Pending | Sep 18, 2023 |
| 18469512 | EFFECTOR PROTEINS, EFFECTOR PARTNERS, COMPOSITIONS, SYSTEMS AND METHODS OF USE THEREOF | Mammoth Biosciences, Inc. | HIBBERT, CATHERINE S | 1658 | §103 | Non-Final OA | 12d | Pending | Sep 18, 2023 |
| 18241603 | MULTI-TENANCY ARCHITECTURE | Secturion Systems, Inc. | JAMSHIDI, GHODRAT | 2493 | §103 | Non-Final OA | 28d | Pending | Sep 01, 2023 |
| 18264753 | ELECTRO-STIMULATION SYSTEMS AND METHODS FOR REHABILITATION AND TREATMENT OF PELVIC DISORDERS | Comphya SA | FAIRCHILD, MALLIKA DIPAYAN | 3792 | §102 | Final Rejection | 23d overdue | Pending | Aug 08, 2023 |
| 18225372 | LOCALLY-STORED REMOTE BLOCK DATA INTEGRITY | Secturion Systems, Inc. | RAHIM, MONJUR | 2436 | — | Final Rejection | 13d | Pending | Jul 24, 2023 |
| 18334327 | METHODS AND COMPOSITIONS FOR PERFORMING A DETECTION ASSAY | Mammoth Biosciences, Inc. | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | §103 | Non-Final OA | 34d | Pending | Jun 13, 2023 |
| 18322436 | METHODS FOR DIRECT SODIUM REMOVAL IN PATIENTS HAVING HEART FAILURE AND RENAL DYSFUNCTION | Dsrco BV | FREDRICKSON, COURTNEY B | 3783 | §103 | Final Rejection | 16d | Pending | May 23, 2023 |
| 18030613 | GENE THERAPY FOR OCULAR MANIFESTATIONS OF CLN2 DISEASE | Tern Therapeutics, LLC | THUESON, HANNA MARIE | 1638 | §103 | Non-Final OA | 19d overdue | Pending | Apr 06, 2023 |
| 18131105 | Devices and Methods for Improving the Longevity of a Wig Installation | Ave Enterprise Group | STEITZ, RACHEL RUNNING | 3772 | §103 | Non-Final OA | 141d overdue | Pending | Apr 05, 2023 |
| 18296296 | ENGINEERED CD200R ANTIBODIES AND USES THEREOF | Gilead Sciences, Inc. | HOWARD, ZACHARY C | 1674 | §112 | Non-Final OA | 22d overdue | Pending | Apr 05, 2023 |
| 18194151 | Pregnancy clock proteins for predicting due date and time to birth | Sera Prognostics, Inc. | COUNTS, GARY W | 1678 | §112 | Final Rejection | 56d overdue | Pending | Mar 31, 2023 |
| 18193532 | TUMESCENSE MONITORING SYSTEM FOR DIAGNOSING ERECTILE DYSFUNCTION AND METHODS OF USE | ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE | COX, THADDEUS B | 3791 | §103 | Non-Final OA | 35d overdue | Pending | Mar 30, 2023 |
| 18028457 | ENGINEERED iPSC AND ARMED IMMUNE EFFECTOR CELLS | Fate Therapeutics, Inc. | GODDARD, LAURA B | 1642 | Other | Non-Final OA | 1d overdue | Pending | Mar 24, 2023 |
| 18183002 | METHODS OF ANALYZING NUCLEIC ACID FRAGMENTS | Grail, Inc. | WILDER, CYNTHIA B | 1681 | — | Non-Final OA | 175d overdue | Pending | Mar 13, 2023 |
| 18011145 | METHYLATED DNA FRAGMENT ENRICHMENT, METHODS, COMPOSITIONS AND KITS | Grail, Inc. | SALMON, KATHERINE D | 1682 | §103 | Final Rejection | 23d | Pending | Dec 16, 2022 |
| 18001571 | UNA OLIGOMERS FOR THE TREATMENT OF POLYGLUTAMINE DISEASES | Arcturus Therapeutics, Inc. | VANHORN, ABIGAIL LOUISE | 1636 | Other | Non-Final OA | 43d overdue | Pending | Dec 12, 2022 |
| 18001367 | BTLA ANTIBODIES | Mirobio Limited | GODDARD, LAURA B | 1642 | DPOther | Non-Final OA | 68d | Pending | Dec 09, 2022 |
| 18000640 | PROGRAMMABLE NUCLEASES AND METHODS OF USE | Mammoth Biosciences, Inc. | RAVINDRA, KRISHNA NUGGEHALLI | 1636 | §103 | Non-Final OA | 71d overdue | Pending | Dec 02, 2022 |
| 18056410 | ENGINEERED PD-1 ANTIBODIES AND USES THEREOF | Mirobio Limited | CHATTIN, AMY MARIE | 1643 | §103 | Non-Final OA | 2d overdue | Pending | Nov 17, 2022 |
| 18052505 | LIPID FORMULATIONS CONTAINING NUCLEIC ACIDS AND METHODS OF TREATMENT FOR CYSTIC FIBROSIS | Arcturus Therapeutics, Inc. | WARD, PAUL V | 1622 | §103 | Non-Final OA | 71d overdue | Pending | Nov 03, 2022 |
| 17964798 | NUCLEIC ACID CONSTRUCTS AND METHODS OF USE | Prognosys Biosciences, Inc. | GREENE, CAROLYN LEE | 1681 | §103 | Non-Final OA | 51d overdue | Pending | Oct 12, 2022 |
| 18045270 | SYSTEMS AND METHODS FOR RENDERING CANNABIS WASTE FOR COMPOSTING | Narc Destroyer, LLC | SHERMAN, ERIC SCOTT | 1736 | Other | Non-Final OA | 113d overdue | Pending | Oct 10, 2022 |
| 17935042 | EFFECTOR PROTEINS AND METHODS OF USE | Mammoth Biosciences, Inc. | LIPPOLIS, ALEXANDRA ROSE | 1637 | Other | Non-Final OA | 29d | Pending | Sep 23, 2022 |
| 17931016 | METHODS FOR ANALYSIS OF TARGET MOLECULES IN BIOLOGICAL FLUIDS | Grail, Inc. | HAQ, SHAFIQUL | 1678 | §103 | Non-Final OA | 20d | Pending | Sep 09, 2022 |
| 17900935 | DUAL-PROBE DIGITAL DROPLET PCR STRATEGY FOR SPECIFIC DETECTION OF TISSUE-SPECIFIC CIRCULATING DNA MOLECULES | Hadasit Medical Research Services & Development Ltd. | DAUNER, JOSEPH G | 1682 | Other | Non-Final OA | 88d overdue | Pending | Sep 01, 2022 |
| 17796553 | PROBIOTIC FORMULATION AND DELIVERY | Austrianova Singapore Pte. Ltd. | SHELLHAMMER, JAMES PAUL | 1793 | §103 | Final Rejection | 2d overdue | Pending | Jul 29, 2022 |
| 17839272 | Methods and Reagents for Molecular Barcoding | Cs Genetics Limited | KAUP, SAHANA S | 1612 | Other | Non-Final OA | 147d overdue | Pending | Jun 13, 2022 |
| 17782600 | ENHANCEMENT OF iPSC-DERIVED EFFECTOR IMMUNE CELL USING SMALL COMPOUNDS | Fate Therapeutics, Inc. | WESTON, ALYSSA G | 1633 | Other | Final Rejection | 30d overdue | Pending | Jun 03, 2022 |
| 17746361 | APPLYING PULSED ELECTRIC FIELDS IN THE TREATMENT OF NEURAL DISORDERS | Galvanize Therapeutics, Inc. | BLAISE, BRADFORD CHRISTOPHER | 3794 | §103 | Non-Final OA | 71d overdue | Pending | May 17, 2022 |
| 17737690 | IONIZABLE CATIONIC LIPIDS FOR RNA DELIVERY | Arcturus Therapeutics, Inc. | KELLY-O'NEILL, YOLANDA LYNNETTE | 1692 | §103 | Non-Final OA | 24d overdue | Pending | May 05, 2022 |
| 17697504 | ALDEHYDE DEHYDROGENASE VARIANTS AND METHODS OF USE | Genomatica, Inc. | EPSTEIN, TODD MATTHEW | 1652 | Other | Non-Final OA | 55d | Pending | Mar 17, 2022 |
| 17693129 | MULTIPLEXED GENOTYPING ASSAYS WITH A SINGLE PROBE USING FLUORESCENT AMPLITUDE TUNING | Gt Molecular, LLC | HOPPE, EMMA RUTH | 1683 | §102 | Final Rejection | 45d overdue | Pending | Mar 11, 2022 |
| 17687498 | PROGRAMMABLE NUCLEASE COMPOSITIONS AND METHODS OF USE THEREOF | Mammoth Biosciences, Inc. | DIBRINO, MARIANNE | 1641 | Other | Final Rejection | 70d | Pending | Mar 04, 2022 |
| 17681060 | METHODS AND SYSTEMS FOR RNA-SEQ PROFILING | Honeycomb Biotechnologies, Inc. | PARISI, JESSICA DANIELLE | 1684 | §103 | Non-Final OA | 110d overdue | Pending | Feb 25, 2022 |
| 17629895 | COMPOSITIONS FOR DETECTION OF DNA AND METHODS OF USE THEREOF | Mammoth Biosciences, Inc. | SCHLOOP, ALLISON ELIZABETH | 1683 | §112 | Non-Final OA | 7d | Pending | Jan 25, 2022 |
| 17646858 | IMPLANTABLE PUMP HAVING INFECTION MONITORING FEATURE | Sequana Medical NV | WENG, KAI H | 3781 | §103 | Non-Final OA | 8d overdue | Pending | Jan 03, 2022 |
| 17555236 | ASSAYS AND METHODS FOR DETECTION OF NUCLEIC ACIDS | Mammoth Biosciences, Inc. | WHITE, DENNIS MICHAEL | 1758 | §103 | Final Rejection | 22d | Pending | Dec 17, 2021 |
| 17620526 | Reagents and Methods for the Analysis of Microparticles | Cs Genetics Limited | CHUNDURU, SURYAPRABHA | 1681 | Other | Non-Final OA | 31d overdue | Pending | Dec 17, 2021 |
| 17505287 | STENT FOR THE POSITIONING AND ANCHORING OF A VALVULAR PROSTHESIS IN AN IMPLANTATION SITE IN THE HEART OF A PATIENT | Jenavalve Technology, Inc. | GANESAN, SUBA | 3774 | §103 | Non-Final OA | 45d overdue | Pending | Oct 19, 2021 |
| 17438317 | CD3 RECONSTITUTION IN ENGINEERED iPSC AND IMMUNE EFFECTOR CELLS | Fate Therapeutics, Inc. | GONZALES, JOSEPHINE MARIA | 1631 | §103 | Final Rejection | 27d | Pending | Sep 10, 2021 |
| 17464341 | COMPOSITIONS AND METHODS FOR ACCURATELY IDENTIFYING MUTATIONS | Fred Hutchinson Cancer Center | ZHANG, KAIJIANG | 1684 | §102 | Non-Final OA | 65d | Pending | Sep 01, 2021 |
| 17412105 | COMPOSITIONS AND METHODS FOR ACCURATELY IDENTIFYING MUTATIONS | Fred Hutchinson Cancer Center | ZHANG, KAIJIANG | 1684 | §102 | Non-Final OA | 65d | Pending | Aug 25, 2021 |
| 17393609 | DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE | Grail, Inc. | DAUNER, JOSEPH G | 1682 | §103 | Final Rejection | 132d overdue | Pending | Aug 04, 2021 |
| 17384251 | DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE | Grail, Inc. | SALMON, KATHERINE D | 1682 | §103 | Final Rejection | 84d overdue | Pending | Jul 23, 2021 |
| 17384241 | DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE | Grail, Inc. | BUCHANAN, BAILEY CHEYENNE | 1682 | §103 | Final Rejection | 23d | Pending | Jul 23, 2021 |
| 17311271 | MODIFIED PROTEINS AND ASSOCIATED METHODS OF TREATMENT | Arcturus Therapeutics, Inc. | DACE DENITO, ALEXANDRA GERALDINE | 1636 | §103 | Final Rejection | 70d | Pending | Jun 04, 2021 |
| 17238060 | HEART VALVE TREATMENT DEVICE AND METHOD | The Provost, Fellows Foundation Scholars, And The Other Members Of The Board, Of The College Of The | WILLSE, DAVID H | 3774 | §102 | Non-Final OA | 36d overdue | Pending | Apr 22, 2021 |
| 17137851 | Accessory Mount | Feradyne Outdoors, LLC | ALMATRAHI, SAHAR FARIS | 3643 | §103 | Non-Final OA | 8d | Pending | Dec 30, 2020 |
| 17040951 | ENGINEERED IMMUNE EFFECTOR CELLS AND USE THEREOF | Fate Therapeutics, Inc. | DHAR, MATASHA | 1632 | §103 | Non-Final OA | 44d overdue | Pending | Sep 23, 2020 |
| 16919947 | BIOMARKERS AND METHODS FOR PREDICTING PREECLAMPSIA | Sera Prognostics, Inc. | BUNKER, AMY M | 1684 | §102 | Final Rejection | 33d | Pending | Jul 02, 2020 |
| 16630547 | DNA TARGETS AS TISSUE-SPECIFIC METHYLATION MARKERS | Hadasit Medical Research Services And Development Ltd. | WOOLWINE, SAMUEL C | 1681 | §101 | Final Rejection | 29d | Pending | Jan 13, 2020 |
| 15651929 | PROCESS AND SYSTEMS FOR OBTAINING 1,4-BUTANEDIOL FROM FERMENTATION BROTHS | Genomatica, Inc. | HOBSON, STEPHEN | 1776 | §103 | Final Rejection | 10d overdue | Pending | Jul 17, 2017 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial